Related references
Note: Only part of the references are listed.Stimuli-responsive nanoparticles for targeting the tumor microenvironment
Jinzhi Du et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA-Wild-Type Triple-Negative Breast Cancer
Olga Karginova et al.
MOLECULAR CANCER THERAPEUTICS (2015)
pH-Sensitive nano-systems for drug delivery in cancer therapy
Juan Liu et al.
BIOTECHNOLOGY ADVANCES (2014)
Use of liposomal doxorubicin-cyclophosphamide combination in breast cancer patients with brain metastases: a monocentric retrospective study
B. Linot et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Particle Replication in Nonwetting Templates Nanoparticles with Tumor Selective Alkyl Silyl Ether Docetaxel Prodrug Reduces Toxicity
Kevin S. Chu et al.
NANO LETTERS (2014)
Current approaches to the treatment of metastatic brain tumours
Taofeek K. Owonikoko et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Selective Permeabilization of the BloodBrain Barrier at Sites of Metastasis
John J. Connell et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Management of non-small-cell lung cancer: recent developments
Martin Reck et al.
LANCET (2013)
Plasma, tumor and tissue pharmacokinetics of Docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograft
Kevin S. Chu et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2013)
Pharmacokinetics and Efficacy of PEGylated Liposomal Doxorubicin in an Intracranial Model of Breast Cancer
Carey K. Anders et al.
PLOS ONE (2013)
Pharmacokinetics and Antitumor Efficacy of XMT-1001, a Novel, Polymeric Topoisomerase I Inhibitor, in Mice Bearing HT-29 Human Colon Carcinoma Xenografts
Mark D. Walsh et al.
CLINICAL CANCER RESEARCH (2012)
Incorporation and Controlled Release of Silyl Ether Prodrugs from PRINT Nanoparticles
Matthew C. Parrott et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
PRINT: A Novel Platform Toward Shape and Size Specific Nanoparticle Theranostics
Jillian L. Perry et al.
ACCOUNTS OF CHEMICAL RESEARCH (2011)
Potent Engineered PLGA Nanoparticles by Virtue of Exceptionally High Chemotherapeutic Loadings
Elizabeth M. Enlow et al.
NANO LETTERS (2011)
Heterogeneous Blood-Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer
Paul R. Lockman et al.
CLINICAL CANCER RESEARCH (2010)
Medical management of brain metastases from lung cancer
Ryuya Yamanaka
ONCOLOGY REPORTS (2009)
The effect of particle design on cellular internalization pathways
Stephanie E. A. Gratton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Plasma, tumor, and tissue disposition of STEALTH liposomal CKD-602 (S-CKD602) and nonliposomal CKD-602 in mice bearing A375 human melanoma xenografts
William C. Zamboni et al.
CLINICAL CANCER RESEARCH (2007)
High intratumoural accumulation of stealth® liposomal doxorubicin (Caelyx®) in glioblastomas and in metastatic brain tumours
MI Koukourakis et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
